85 related articles for article (PubMed ID: 10811242)
1. Weight gain and antipsychotic medication.
Blackburn GL
J Clin Psychiatry; 2000; 61 Suppl 8():36-41; discussion 42. PubMed ID: 10811242
[TBL] [Abstract][Full Text] [Related]
2. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
Koga M
Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
[TBL] [Abstract][Full Text] [Related]
3. Weight loss in overweight patients maintained on atypical antipsychotic agents.
Centorrino F; Wurtman JJ; Duca KA; Fellman VH; Fogarty KV; Berry JM; Guay DM; Romeling M; Kidwell J; Cincotta SL; Baldessarini RJ
Int J Obes (Lond); 2006 Jun; 30(6):1011-6. PubMed ID: 16432547
[TBL] [Abstract][Full Text] [Related]
4. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
[TBL] [Abstract][Full Text] [Related]
5. Schizophrenia, obesity, and antipsychotic medications: what can we do?
Citrome L; Vreeland B
Postgrad Med; 2008 Jul; 120(2):18-33. PubMed ID: 18654065
[TBL] [Abstract][Full Text] [Related]
6. Weight change with atypical antipsychotics in the treatment of schizophrenia.
Haddad P
J Psychopharmacol; 2005 Nov; 19(6 Suppl):16-27. PubMed ID: 16280334
[TBL] [Abstract][Full Text] [Related]
7. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
Carpiniello B; Corda E; Maccioni R; Pinna F
Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
[TBL] [Abstract][Full Text] [Related]
8. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
9. Weight gain associated with use of psychotropic medications.
Sachs GS; Guille C
J Clin Psychiatry; 1999; 60 Suppl 21():16-9. PubMed ID: 10548137
[TBL] [Abstract][Full Text] [Related]
10. [Body weight changes and psychotropic drug treatment: neuroleptics].
Recasens C
Encephale; 2001; 27(3):269-76. PubMed ID: 11488257
[TBL] [Abstract][Full Text] [Related]
11. Effects of an educational intervention on weight gain in patients treated with antipsychotics.
Mauri M; Castrogiovanni S; Simoncini M; Iovieno N; Miniati M; Rossi A; Dell'Agnello G; Fagiolini A; Donda P; Cassano GB
J Clin Psychopharmacol; 2006 Oct; 26(5):462-6. PubMed ID: 16974185
[TBL] [Abstract][Full Text] [Related]
12. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
13. Obesity, serious mental illness and antipsychotic drugs.
Holt RI; Peveler RC
Diabetes Obes Metab; 2009 Jul; 11(7):665-79. PubMed ID: 19476478
[TBL] [Abstract][Full Text] [Related]
14. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-associated weight gain and clinical outcome parameters.
Blin O; Micallef J
J Clin Psychiatry; 2001; 62 Suppl 7():11-21. PubMed ID: 11346191
[TBL] [Abstract][Full Text] [Related]
16. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
Koponen H; Saari K; Savolainen M; Isohanni M
Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
[TBL] [Abstract][Full Text] [Related]
17. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
18. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
19. Weight gain in the treatment of mood disorders.
Aronne LJ; Segal KR
J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
[TBL] [Abstract][Full Text] [Related]
20. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 4():34-9. PubMed ID: 17539698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
